A 48-year-old woman with biopsy-proven squamous cell carcinoma of the floor of mouth (T2N1M0) is being staged. Which investigation is most appropriate for detecting occult distant metastases and assessing the extent of locoregional disease?

Explanation

## Investigation for Staging and Metastatic Workup in Oral Cavity Carcinoma **Key Point:** 18F-FDG PET-CT is the most sensitive and specific imaging modality for detecting both locoregional disease extent and distant metastases in oral cavity squamous cell carcinoma. ### Why 18F-FDG PET-CT? 1. **Whole-body imaging** — detects occult distant metastases (lung, bone, liver) with high sensitivity (~90%) 2. **Metabolic imaging** — identifies hypermetabolic lesions (malignant) vs. benign inflammatory nodes 3. **Nodal assessment** — superior to CT/MRI for detecting metastatic lymph nodes (size-independent) 4. **Prognostic value** — SUV (standardized uptake value) correlates with tumor aggressiveness 5. **Treatment planning** — influences choice of chemotherapy, radiation fields, and surgical extent ### Clinical Context This patient has: - **T2N1M0** disease (intermediate-sized tumor with ipsilateral lymph node involvement) - **High risk for occult metastases** — floor of mouth tumors have aggressive biology and higher propensity for distant spread - **Need for comprehensive staging** before definitive treatment (surgery ± chemoradiation) **High-Yield:** In head and neck SCC with nodal involvement (N1–N3), PET-CT is recommended by NCCN and ASCO guidelines for staging and treatment planning. ### Comparison of Staging Investigations | Investigation | Locoregional Assessment | Distant Metastasis Detection | Metabolic Info | Cost | |---|---|---|---|---| | Chest X-ray + USG | Poor | Low sensitivity (~60%) | No | Low | | CT (H&N only) | Excellent | Cannot assess abdomen/pelvis | No | Moderate | | MRI (H&N only) | Excellent (soft tissue) | Cannot assess distant sites | No | High | | 18F-FDG PET-CT | Good (nodal) | Excellent (~90%) | Yes (SUV) | High | **Clinical Pearl:** While contrast-enhanced CT of the head and neck is excellent for assessing primary tumor extent and locoregional lymph nodes, it **cannot adequately assess the chest, abdomen, and pelvis** for distant metastases. PET-CT fills this gap with superior sensitivity for occult disease. ### Mermaid: Staging Algorithm for Oral Cavity SCC ```mermaid flowchart TD A[Biopsy-proven oral cavity SCC]:::outcome --> B{Stage?}:::decision B -->|T1N0M0| C[CT H&N + CXR]:::action B -->|T2-4 or N1-3| D[PET-CT head/neck/chest/abdomen]:::action D --> E{Distant mets?}:::decision E -->|No| F[Locoregional treatment planning]:::action E -->|Yes| G[Palliative/systemic therapy]:::urgent C --> H[Locoregional treatment]:::action ``` **Mnemonic for PET-CT advantages:** **SWAMI** - **S**ensitivity for distant metastases - **W**hole-body coverage - **A**ssesses metabolic activity (SUV) - **M**ultiple organ assessment - **I**nfluences treatment intensity [cite:Harrison 21e Ch 297; NCCN Head & Neck Cancer Guidelines 2023]